Synthesis, Biological Evaluation, and Molecular Modeling of Natural and Unnatural Flavonoidal Alkaloids, Inhibitors of Kinases

Journal of Medicinal Chemistry
2012.0

Abstract

The screening of the ICSN chemical library on various disease-relevant protein kinases led to the identification of natural flavonoidal alkaloids of unknown configuration as potent inhibitors of the CDK1 and CDK5 kinases. We thus developed an efficient and modular synthetic strategy for their preparation and that of analogues in order to determine the absolute configuration of the active natural flavonoidal alkaloids and to provide further insights on the structure-activity relationships in this series. The structural determinants of the interaction between some flavonoidal alkaloids with specific kinases were also evaluated using molecular modeling.

Knowledge Graph

Similar Paper

Synthesis, Biological Evaluation, and Molecular Modeling of Natural and Unnatural Flavonoidal Alkaloids, Inhibitors of Kinases
Journal of Medicinal Chemistry 2012.0
Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: Synthesis, SAR analysis, and biological activity
Bioorganic & Medicinal Chemistry 2008.0
Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues
Bioorganic & Medicinal Chemistry 2007.0
A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs
Bioorganic & Medicinal Chemistry 2019.0
Structure–activity relationship studies of flavopiridol analogues
Bioorganic & Medicinal Chemistry Letters 2000.0
Discovery and Synthesis of a Naturally Derived Protein Kinase Inhibitor that Selectively Inhibits Distinct Classes of Serine/Threonine Kinases
Journal of Natural Products 2023.0
Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency
European Journal of Medicinal Chemistry 2020.0
Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay
European Journal of Medicinal Chemistry 2010.0
Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors
Bioorganic & Medicinal Chemistry 2018.0